Blood & Plasma Components Market - Global Forecast 2026-2032

The blood and plasma components market is experiencing significant change as healthcare systems and suppliers realign strategies to keep pace with clinical advances, regulatory shifts, and the need for greater supply chain resilience. Senior leaders navigating this evolving environment must leverage actionable insights to sustain competitive advantage and ensure access to essential therapies.

Market Snapshot: Blood & Plasma Components Market Growth

The Blood & Plasma Components Market is on a steady growth trajectory, expanding from USD 7.60 billion in 2025 to USD 8.21 billion in 2026, with a projected CAGR of 8.43%. By 2032, the market is forecasted to reach USD 13.41 billion. This robust expansion is fueled by rising clinical utilization of plasma proteins, cellular constituents, and derivative therapeutics in diagnostic, research, and clinical applications. The intersection of increasing demand and complex supply mechanisms presents both opportunities and ongoing challenges for stakeholders across the value chain.

Scope & Segmentation

Product Types: Plasma proteins such as albumin and specialized classes like coagulation factors and immunoglobulins; cellular components including platelets, red blood cells, and white blood cells.
Therapeutic Categories: Includes coagulation factors (Factor IX, Factor VIII, prothrombin complex concentrates) and immunoglobulins administered via intravenous or subcutaneous delivery.
Application Areas: Encompasses diagnostic, research, and therapeutic scenarios, each requiring exacting supply chain procedures and clinical oversight.
End Users: Targeted users include diagnostic laboratories, research organizations, and hospitals spanning private, government, and ambulatory surgical centers.
Distribution Channels: Involves hospital pharmacies, online pharmacies, and retail pharmacies, each facing unique regulatory and environmental controls.
Geographic Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific, with procurement and regulatory practices tailored to the local healthcare context.
Core Technologies: Advances such as plasma fractionation, recombinant product manufacturing, cold chain logistics, digital inventory management, and point-of-care testing platforms.

Key Takeaways: Strategic Insights for Decision-Makers

Operational resilience shapes supplier interactions and procurement, prompting healthcare providers to prioritize innovation adoption in both clinical and commercial workflows.
Segmentation is vital; for example, tailored inventory management for labile products like platelets and immunoglobulins enhances availability and patient safety across multiple healthcare platforms.
Continuous evolution of distribution channels heightens the need for adaptable, compliant cold chains to support uninterrupted diagnostic and therapeutic supply.
Effective risk mitigation relies on broad-based collaboration, from manufacturers to research institutions, facilitating diversified sourcing and strategic partnerships.
Utilizing real-world evidence, adaptive clinical trial frameworks, and post-market surveillance is increasingly core to regulatory submissions and agile product development.

Tariff Impact on Cross-Border Supply Chains

Recent tariffs imposed in the United States have prompted a thorough reassessment of procurement and sourcing strategies within the blood and plasma components market. These tariffs, particularly on ancillary supplies and select biological materials, add operational and administrative layers of complexity. In response, industry players are investing in local production capabilities, building regional capacity, and forming closer logistics partnerships. This environment forces both buyers and suppliers to factor in landed costs, compliance demands, and overall cross-border resilience during strategic and operational planning.

Methodology & Data Sources

The analysis integrates both qualitative and quantitative research, drawing on structured interviews with stakeholders such as clinicians, procurement leads, and supply chain managers. Further, the report synthesizes findings from regulatory documents, peer-reviewed literature, and detailed supply chain mapping to present a comprehensive assessment of market realities.

Why This Report Matters

Delivers segmentation-relevant intelligence to inform product positioning, application diversification, and strategic market entry.
Assists stakeholders in enhancing supply strategies, streamlining clinical and logistical implementation, and driving forward regulatory-compliant innovation.
Equips leaders with timely, region-specific guidance to address evolving technological, distribution, and compliance trends in key geographic sectors.

Conclusion

Success in the blood and plasma components sector depends on integrating clinical effectiveness, compliance adherence, and operational stability. Implementing targeted recommendations helps organizations deliver reliable therapy access and uphold critical healthcare service standards.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Blood & Plasma Components Market, by Product Type

8.1. Plasma Proteins
8.1.1. Albumin
8.1.2. Coagulation Factors
8.1.3. Immunoglobulins
8.1.3.1. Intravenous Immunoglobulin
8.1.3.2. Subcutaneous Immunoglobulin
8.2. Platelets
8.3. Red Blood Cells
8.4. White Blood Cells

9. Blood & Plasma Components Market, by Distribution Channel

9.1. Hospital Pharmacies
9.2. Online Pharmacies
9.3. Retail Pharmacies

10. Blood & Plasma Components Market, by Application

10.1. Diagnostic
10.2. Research
10.3. Therapeutic

11. Blood & Plasma Components Market, by End User

11.1. Diagnostic Laboratories
11.2. Hospitals
11.2.1. Ambulatory Surgical Centers
11.2.2. Government Hospitals
11.2.3. Private Hospitals
11.3. Research Institutions

12. Blood & Plasma Components Market, by Region

12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific

13. Blood & Plasma Components Market, by Group

13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO

14. Blood & Plasma Components Market, by Country

14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea

15. United States Blood & Plasma Components Market
16. China Blood & Plasma Components Market

17. Competitive Landscape

17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Adma Biologics, Inc.
17.6. Baxter International Inc.
17.7. Becton, Dickinson and Company
17.8. Bio Products Laboratory Limited
17.9. BioLife Plasma Services L.P.
17.10. Biotest AG
17.11. Cerus Corporation
17.12. CSL Limited
17.13. Fapon Biotech Inc.
17.14. Fresenius SE & Co. KGaA
17.15. Grifols, S.A.
17.16. Haemonetics Corporation
17.17. Immucor, Inc.
17.18. Johnson & Johnson Services, Inc.
17.19. KEDRION S.p.A.
17.20. LFB S.A.
17.21. Macopharma S.A.S.
17.22. Medline Industries, LP
17.23. Octapharma AG
17.24. Quotient Limited
17.25. Sanquin Blood Supply Foundation
17.26. Shanghai RAAS Blood Products Co., Ltd
17.27. Takeda Pharmaceutical Company Limited
17.28. Terumo Corporation

List of Figures

FIGURE 1. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BLOOD & PLASMA COMPONENTS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY ALBUMIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY ALBUMIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COAGULATION FACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLATELETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLATELETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLATELETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RED BLOOD CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RED BLOOD CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY WHITE BLOOD CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY WHITE BLOOD CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY WHITE BLOOD CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 105. EUROPE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. EUROPE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 107. EUROPE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2032 (USD MILLION)
TABLE 108. EUROPE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 109. EUROPE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 110. EUROPE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 111. EUROPE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. EUROPE BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 121. AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 123. AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2032 (USD MILLION)
TABLE 124. AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 125. AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 126. AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. AFRICA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. ASEAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. ASEAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 140. ASEAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2032 (USD MILLION)
TABLE 141. ASEAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 142. ASEAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 143. ASEAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 144. ASEAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 145. ASEAN BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 146. GCC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GCC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 148. GCC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2032 (USD MILLION)
TABLE 149. GCC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 150. GCC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 151. GCC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 152. GCC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. GCC BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 162. BRICS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. BRICS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. BRICS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2032 (USD MILLION)
TABLE 165. BRICS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 166. BRICS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 167. BRICS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 168. BRICS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. BRICS BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 170. G7 BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. G7 BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 172. G7 BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2032 (USD MILLION)
TABLE 173. G7 BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 174. G7 BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 175. G7 BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 176. G7 BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. G7 BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 178. NATO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. NATO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 180. NATO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2032 (USD MILLION)
TABLE 181. NATO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 182. NATO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 183. NATO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 184. NATO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 185. NATO BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL BLOOD & PLASMA COMPONENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 188. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 189. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2032 (USD MILLION)
TABLE 190. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 191. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 192. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 193. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. UNITED STATES BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 195. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 196. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 197. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY PLASMA PROTEINS, 2018-2032 (USD MILLION)
TABLE 198. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 199. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 200. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 201. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 202. CHINA BLOOD & PLASMA COMPONENTS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Blood & Plasma Components market report include:

Adma Biologics, Inc.
Baxter International Inc.
Becton, Dickinson and Company
Bio Products Laboratory Limited
BioLife Plasma Services L.P.
Biotest AG
Cerus Corporation
CSL Limited
Fapon Biotech Inc.
Fresenius SE & Co. KGaA
Grifols, S.A.
Haemonetics Corporation
Immucor, Inc.
Johnson & Johnson Services, Inc.
KEDRION S.p.A.
LFB S.A.
Macopharma S.A.S.
Medline Industries, LP
Octapharma AG
Quotient Limited
Sanquin Blood Supply Foundation
Shanghai RAAS Blood Products Co., Ltd
Takeda Pharmaceutical Company Limited
Terumo Corporation

Table Information

Report Attribute	Details
No. of Pages	198
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 8.21 Billion
Forecasted Market Value ( USD ) by 2032	$ 13.41 Billion
Compound Annual Growth Rate	8.4%
Regions Covered	Global
No. of Companies Mentioned	25

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3505EUR$3,939USD£3,044GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3781EUR$4,249USD£3,283GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5125EUR$5,759USD£4,450GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6201EUR$6,969USD£5,385GBP

Market Snapshot: Blood & Plasma Components Market Growth

Scope & Segmentation

Key Takeaways: Strategic Insights for Decision-Makers

Tariff Impact on Cross-Border Supply Chains

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Blood Plasma Derivatives Market - Global Forecast 2026-2032

Plasma Fractionation Market - Global Forecast 2026-2032

Plasma Fractionation Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

Blood Plasma Fractionation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Plasma Fractionation - Global Strategic Business Report